Article
Insights into IL‐29: Emerging role in inflammatory autoimmune diseases
2 Oct 2019
Abstract excerpt
Interleukin-29 (IL-29) is a newly discovered member of type III interferon. It mediates signal transduction via binding to its receptor complex and activates downstream signalling pathways, and therefore induces the generation of inflammatory components. Recent studies reported that expression of IL-29 is dysregulated in inflammatory autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
